Anti‐TNF‐induced lupus in patients with inflammatory bowel disease
Author:
Affiliation:
1. Department of Gastroenterology and HepatologyRoyal Perth Hospital Perth Western Australia Australia
Publisher
Wiley
Subject
Gastroenterology,Hepatology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/jgh3.12291
Reference16 articles.
1. Safety of anti-tumor necrosis factor therapy in inflammatory bowel disease
2. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
3. Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM Trial
4. Meta-analysis of the Efficacy and Safety of Adalimumab, Etanercept, and Infliximab for the Treatment of Rheumatoid Arthritis
5. Autoimmune Diseases Induced by TNF-Targeted Therapies
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The SYSCID map: a graphical and computational resource of molecular mechanisms across rheumatoid arthritis, systemic lupus erythematosus and inflammatory bowel disease;Frontiers in Immunology;2023-11-01
2. Infliximab biosimilar-induced lupus nephritis: A case report;Modern Rheumatology Case Reports;2023-10-31
3. Cytokines in Systemic Lupus Erythematosus—Focus on TNF-α and IL-17;International Journal of Molecular Sciences;2023-09-22
4. Tumor necrosis factor-α inhibitor-related autoimmune disorders;Autoimmunity Reviews;2023-07
5. Focus on Anti-Tumour Necrosis Factor (TNF)-α-Related Autoimmune Diseases;International Journal of Molecular Sciences;2023-05-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3